A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur
NCT03769558 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 264
Last updated 2020-03-20
Summary
This study will determine the incidences of infections and malignancies among JIA patients treated with abatacept
Conditions
- Juvenile Idiopathic Arthritis
Interventions
- OTHER
-
Non-Interventional
Non-Interventional
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-12
- Primary Completion
- 2016-09-30
- Completion
- 2016-09-30
Countries
- United States
Study Locations
More Related Trials
-
BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
NCT00095173 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
NCT01835470 ·Status: COMPLETED ·Phase: PHASE3
-
Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients
NCT01351480 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Study Assessing the Long-Term Safety of Abatacept
NCT02169544 ·Status: COMPLETED
-
Safety Study of Abatacept to Treat Rheumatoid Arthritis
NCT01247766 ·Status: COMPLETED
-
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
NCT00124982 ·Status: COMPLETED ·Phase: PHASE3
-
Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis
NCT02885818 ·Status: COMPLETED
-
Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis
NCT00195819 ·Status: COMPLETED ·Phase: PHASE3
-
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
NCT02037737 ·Status: COMPLETED
-
Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural Damage
NCT01333878 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT00048568 ·Status: COMPLETED ·Phase: PHASE3
-
Real-world Clinical Efficacy of Abatacept in the T3 Data Registry
NCT01555879 ·Status: COMPLETED
-
Effects of Abatacept on Myocarditis in Rheumatoid Arthritis
NCT03619876 ·Status: TERMINATED ·Phase: PHASE4
-
Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)
NCT01088321 ·Status: COMPLETED
-
A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197
NCT02429895 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis
NCT00484289 ·Status: COMPLETED ·Phase: PHASE3
-
Phase IIIB Subcutaneous Abatacept Monotherapy Study
NCT00547521 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis
NCT03882008 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis
NCT01500551 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients
NCT00124449 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)
NCT01088360 ·Status: ACTIVE_NOT_RECRUITING
-
Methotrexate-Inadequate Response Study
NCT00559585 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS)
NCT05861128 ·Status: RECRUITING ·Phase: PHASE3
-
Study on the Safety of Abatacept in Relapsing Polychondritis
NCT01272856 ·Status: COMPLETED ·Phase: PHASE1
-
Phase IIIB Subcutaneous Missed Dose Study
NCT00533897 ·Status: COMPLETED ·Phase: PHASE3